119 related articles for article (PubMed ID: 11605731)
1. Clinical significance of epidermal growth factor receptor content in gastric cancer.
García I; Vizoso F; Andicoechea A; Raigoso P; Vérez P; Alexandre E; García-Muñiz JL; Allende MT
Int J Biol Markers; 2001; 16(3):183-8. PubMed ID: 11605731
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
García I; Vizoso F; Martín A; Sanz L; Abdel-Lah O; Raigoso P; García-Muñiz JL
Ann Surg Oncol; 2003 Apr; 10(3):234-41. PubMed ID: 12679307
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
García I; del Casar JM; Corte MD; Allende MT; García-Muñiz JL; Vizoso F
Int J Biol Markers; 2003; 18(3):200-6. PubMed ID: 14535591
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.
Al-Moundhri MS; Al-Hadabi I; Al-Mawaly K; Kumar S; Al-Lawati FA; Bhatnager G; Kuruvila S; Al-Hamdani A; El-Sayed SM; Al-Bahrani B
Med Oncol; 2012 Sep; 29(3):1739-47. PubMed ID: 22048943
[TBL] [Abstract][Full Text] [Related]
5. Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection.
Lee SA; Choi SR; Jang JS; Lee JH; Roh MH; Kim SO; Kim MC; Kim SJ; Jeong JS
Dig Dis Sci; 2010 Jul; 55(7):1955-63. PubMed ID: 19757047
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
[TBL] [Abstract][Full Text] [Related]
7. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS; Kim MA; Kim TM; Lee SH; Kim DW; Im SA; Kim TY; Kim WH; Yang HK; Heo DS; Bang YJ; Lee KU; Choe KJ; Kim NK
Br J Cancer; 2009 Mar; 100(5):732-8. PubMed ID: 19259093
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.
del Casar JM; Corte MD; Alvarez A; García I; Bongera M; González LO; García-Muñiz JL; Allende MT; Astudillo A; Vizoso FJ
J Cancer Res Clin Oncol; 2008 Feb; 134(2):153-61. PubMed ID: 17628829
[TBL] [Abstract][Full Text] [Related]
9. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
11. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
[TBL] [Abstract][Full Text] [Related]
12. The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer.
Li GC; Jia XC; Zhao QC; Zhang HW; Yang P; Xu LL; Pang FN; Sun JB
Medicine (Baltimore); 2020 May; 99(21):e20460. PubMed ID: 32481349
[TBL] [Abstract][Full Text] [Related]
13. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
[TBL] [Abstract][Full Text] [Related]
16. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma.
Ito R; Nakayama H; Yoshida K; Matsumura S; Oda N; Yasui W
Virchows Arch; 2004 Apr; 444(4):324-31. PubMed ID: 14991403
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I-III gastric cancer.
Li G; Wang N; Sun C; Li B
World J Surg Oncol; 2014 Mar; 12():72. PubMed ID: 24678890
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.
Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Sima HR; Esmaili-Shandiz E; Hosseinnezhad H; Taghizadeh-Kermani A; Moaven O; Bahrani M
World J Gastroenterol; 2008 Nov; 14(41):6376-81. PubMed ID: 19009655
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
